查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1663515

CRISPR 和 Cas 基因市场，按产品、按应用、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

CRISPR and Cas Gene Market, By Product, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年 CRISPR 和 Cas 基因市场规模价值为 48.9943 亿美元，2025 年至 2032 年的复合年增长率为 16.90%。

CRISPR 和 Cas 基因市场-市场动态

医疗保健和农业领域对精准基因编辑工具的需求不断增长

由于 CRISPR-Cas 系统等精准基因编辑工具的变革潜力和成本效益，医疗保健和农业领域对其的需求正在激增。在医疗保健领域，CRISPR 透过直接纠正致病突变实现了对遗传疾病的突破性治疗。例如，它在治疗镰状细胞性贫血和β-地中海贫血方面已显示出良好的效果。此外，该技术在癌症免疫治疗中至关重要，其中工程化 T 细胞可以靶向特定的肿瘤细胞，从而推动个人化医疗的发展。全球遗传疾病的增多影响了数百万人，这是在治疗研究中采用 CRISPR 技术的关键驱动力。据世界卫生组织 (WHO) 称，大约 10,000 种单基因疾病可以透过基因编辑的进步来治疗。在农业领域，CRISPR 正在重新定义作物工程，使科学家能够开发抗虫、耐旱和营养丰富的作物，以应对粮食不安全问题。它透过减少对化学农药和化肥的依赖来支持永续农业。美国农业部（USDA）在2023年报告称，基因编辑作物可以在未来十年内将粮食产量提高高达30％，强调了该技术解决全球农业挑战的潜力。与 ZFN 和 TALEN 等旧技术相比，CRISPR 在这些领域的应用日益广泛，这得益于它的精确性、效率和经济性，从而改变了医药和食品生产领域的格局。

CRISPR 和 Cas 基因市场 - 关键见解

  • 根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 16.90%
  • 根据产品细分，预计 CRISPR 产品将在 2024 年占据最大市场份额
  • 根据最终用户细分，製药和生物技术公司是 2024 年的领先细分市场
  • 从地区来看，北美是 2024 年最大的收入来源

CRISPR 和 Cas 基因市场-細項分析：

全球 CRISPR 和 Cas 基因市场根据产品、应用、最终用户和地区进行细分。

根据产品，市场分为两类：CRISPR 产品和 CRISPR 服务。 CRISPR 产品因其在基因编辑、研究和治疗开发中的广泛应用而占据市场主导地位，具有无与伦比的精度和效率。使用者友善试剂盒、试剂和先进的 Cas 蛋白的出现推动了医疗保健、农业和生物技术产业的快速应用。

根据最终用户，市场分为三类：製药和生物技术公司、学术和研究机构以及合约研究组织。製药和生物技术公司在药物发现、基因疾病治疗和个人化医疗开发的基因编辑技术方面进行了大量投资，从而占据了市场主导地位。他们强大的研究基础设施和对临床试验的关注加速了基于 CRISPR 的创新解决方案的商业化，推动了市场成长。

CRISPR 和 Cas 基因市场-地理洞察：

CRISPR 和 Cas 基因市场表现出明显的区域差异，这是由技术进步、研究资金、监管框架和市场采用方面的差异造成的。北美引领全球市场，这归功于对基因编辑技术的大量投资、强劲的生物技术产业以及政府的支持政策。美国尤其占据主导地位，因为它开展了广泛的研究计划，并且领先的製药公司和研究机构之间开展了合作。根据美国国立卫生研究院（NIH）介绍，近年来美国政府为CRISPR相关研究计画拨款超过10亿美元。由于强大的学术研究基础设施和 CRISPR 技术在治疗应用中的日益普及，欧洲占据着突出的市场份额。德国、英国和法国等国家处于 CRISPR 创新的前沿，尤其是在农业生物技术和精准医疗领域。然而，围绕基因改造的监管限制仍然是一个挑战。亚太地区正经历快速成长，主要得益于中国、日本和韩国等国家生物技术产业的扩张。中国已成为主要参与者，积极投资基因编辑研究和临床应用，特别是在农业和疾病治疗领域。该地区对食品安全和个人化医疗的日益关注进一步加速了需求。在农业进步和医疗保健现代化的推动下，拉丁美洲和中东及非洲的新兴市场正逐步采用 CRISPR 技术。

CRISPR 与 Cas 基因市场-竞争格局：

CRISPR 和 Cas 基因市场竞争激烈，老牌企业和新兴生物技术公司齐聚一堂，推动各类应用的创新。市场上的公司正专注于开发先进的基于 CRISPR 的产品，例如基因编辑试剂盒、试剂和 CRISPR 相关服务，以满足製药、生物技术和农业领域日益增长的需求。这些公司投入巨资进行研发，以提高 CRISPR 技术的精确度、效率和可扩展性，这对于成功商业化至关重要。竞争格局的特点是策略伙伴关係、协作和收购，旨在扩大产品组合和市场范围。主要参与者也与学术机构和研究组织建立联盟，以加速开发新的基因编辑工具和疗法。此外，各公司正在透过探索传统医疗保健和农业以外的应用（例如工业生物技术和环境应用）来实现产品多样化，以获得竞争优势。随着基于 CRISPR 的疗法和农产品获得越来越多的监管批准，市场参与者正在为新兴市场的长期成长做好准备，这在应对多样化的监管环境中既带来了机会，也带来了挑战。整体而言，竞争非常激烈，竞争的驱动力是技术进步、创新和策略性业务扩张。

最新动态：

  • 2024年4月，Cellistic成功从Artisan Bio收购了STAR-CRISPR Cas-12基因编辑技术平台及其全部智慧财产权组合，增强了其在基于iPSC的同种异体细胞治疗方面的能力。此次收购巩固了 Cellistic 在基因编辑领域的领先地位，为细胞治疗开发提供了高精度和高效率，并且能够实现比传统 CRISPR 技术更精确的客製化编辑。
  • 2024 年 7 月，Ncardia 收购了 STAR-CRISPR 技术，以增强诱导多能干细胞 (iPSC) 中的基因编辑，从而实现高效率的基因敲入和敲除，同时最大程度地减少脱靶效应。此次收购透过提供更准确的疾病模型和先进的细胞疗法增强了他们在药物研发和再生医学方面的能力。
  • 2024 年 3 月，理光与 ERS ​​Genomics 达成许可协议，以在美国和日本使用 CRISPR/Cas9 基因组编辑技术。此次合作加上理光对 Elixirgen Scientific 的收购，旨在利用 CRISPR 创建可靠的疾病模型，缩短药物开发时间并提高成功率，从而加速药物发现、个人化医疗和再生医学。

目录

第 1 章：CRISPR 和 Cas 基因市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • CRISPR 和 Cas 基因市场产品摘要
    • CRISPR 和 Cas 基因市场片段（按应用）
    • CRISPR 和 Cas 基因市场片段（按最终用户）
    • CRISPR 和 Cas 基因市场片段（按国家/地区）
    • CRISPR 和 Cas 基因市场片段（按地区）
  • 竞争洞察

第 3 章：CRISPR 和 Cas 基因关键市场趋势

  • CRISPR 和 Cas 基因市场驱动因素
    • 市场驱动因素的影响分析
  • CRISPR 和 Cas 基因市场限制
    • 市场限制的影响分析
  • CRISPR 和 Cas 基因市场机会
  • CRISPR 和 Cas 基因市场未来趋势

第 4 章：CRISPR 和 Cas 基因产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：CRISPR 与 Cas 基因市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：CRISPR 和 Cas 基因市场模式

  • 2024 年 CRISPR 和 Cas 基因市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：CRISPR 和 Cas 基因市场 - 按产品

  • 概述
    • 按产品细分的份额分析
    • CRISPR 产品
    • CRISPR 服务

第 8 章：CRISPR 和 Cas 基因市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 生物医学应用
    • 农业应用
    • 工业应用

第 9 章：CRISPR 和 Cas 基因市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药和生物技术公司
    • 学术及研究机构
    • 合约研究组织

第 10 章：CRISPR 和 Cas 基因市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美 CRISPR 和 Cas 基因关键製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品划分）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲 CRISPR 和 Cas 基因关键製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（依产品划分）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区 CRISPR 和 Cas 基因关键製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依产品划分）
    • 亚太地区市场规模及预测（按应用划分）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲的 CRISPR 和 Cas 基因关键製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲的 CRISPR 和 Cas 基因关键製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模及预测（依产品划分）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析- CRISPR 和 Cas 基因产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Thermo Fisher Scientific
    • Editas Medicine
    • CRISPR Therapeutics
    • Intellia Therapeutics
    • Caribou Biosciences
    • Horizon Discovery
    • Synthego Corporation
    • Agilent Technologies
    • GenScript Biotech
    • Takara Bio
    • Promega Corporation
    • MilliporeSigma
    • Bio-Rad Laboratories
    • New England Biolabs
    • Beam Therapeutics
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4717

REPORT HIGHLIGHT

CRISPR and Cas Gene Market size was valued at US$ 4,899.43 Million in 2024, expanding at a CAGR of 16.90% from 2025 to 2032.

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) Genes form a groundbreaking gene-editing technology that allows precise alterations in DNA sequences. CRISPR acts as a natural immune defense mechanism in bacteria, while Cas proteins (such as Cas9) serve as molecular scissors guided by RNA to cut specific DNA strands. This system's ability to edit genes with unmatched accuracy has revolutionized genetic research and therapeutic development. The need for CRISPR-Cas technology stems from its potential to address genetic disorders by directly modifying faulty genes. Unlike traditional gene therapies, CRISPR is faster, cost-effective, and more precise, making it a superior choice for treating inherited diseases. It plays a pivotal role in personalized medicine, where tailored genetic interventions offer targeted treatment. Moreover, in agriculture, CRISPR enhances crop yields, pest resistance, and nutritional content, improving global food security. CRISPR's importance lies in its vast applications across healthcare, agriculture, and scientific research. It offers hope for curing genetic diseases like cystic fibrosis and sickle cell anemia, drives innovation in cancer immunotherapy, and aids in developing new antiviral treatments. Additionally, it empowers fundamental biological research by enabling detailed studies of gene functions. CRISPR-Cas technology continues to reshape science, holding transformative potential for human health and sustainability.

CRISPR and Cas Gene Market- Market Dynamics

Rising demand for precise gene-editing tools in healthcare and agriculture

The demand for precise gene-editing tools like CRISPR-Cas systems is surging in healthcare and agriculture due to their transformative potential and cost-effectiveness. In healthcare, CRISPR enables groundbreaking therapies for genetic disorders by directly correcting disease-causing mutations. For instance, it has shown promising results in treating sickle cell anemia and beta-thalassemia. Additionally, the technology is pivotal in cancer immunotherapy, where engineered T cells target specific tumor cells, advancing personalized medicine. The global rise in genetic disorders, affecting millions, is a key driver for adopting CRISPR technology in therapeutic research. According to the World Health Organization (WHO), approximately 10,000 monogenic diseases can potentially be treated through gene-editing advancements. In agriculture, CRISPR is redefining crop engineering, allowing scientists to develop pest-resistant, drought-tolerant, and nutritionally enhanced crops to combat food insecurity. It supports sustainable farming by reducing dependence on chemical pesticides and fertilizers. The U.S. Department of Agriculture (USDA) reported in 2023 that gene-edited crops could boost food production by up to 30% over the next decade, emphasizing the technology's potential to address global agricultural challenges. The rising adoption of CRISPR across these sectors is driven by its precision, efficiency, and affordability compared to older techniques like ZFNs and TALENs, making it a game-changer in both medicine and food production.

CRISPR and Cas Gene Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.90% over the forecast period (2025-2032)
  • Based on Product segmentation, CRISPR Products was predicted to show maximum market share in the year 2024
  • Based on End-User segmentation, Pharmaceutical and Biotechnology Companies was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

CRISPR and Cas Gene Market- Segmentation Analysis:

The Global CRISPR and Cas Gene Market is segmented on the basis of Product, Application, End-User, and Region.

The market is divided into two categories based on Product: CRISPR Products, and CRISPR Services. CRISPR Products dominate the market due to their widespread application in gene editing, research, and therapeutic development, offering unmatched precision and efficiency. The availability of user-friendly kits, reagents, and advanced Cas proteins has driven rapid adoption across healthcare, agriculture, and biotechnology industries.

The market is divided into three categories based on End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, and Contract Research Organizations. Pharmaceutical and Biotechnology Companies dominate the market due to their extensive investments in gene-editing technologies for drug discovery, genetic disease therapies, and personalized medicine development. Their robust research infrastructure and focus on clinical trials accelerate the commercialization of innovative CRISPR-based solutions, driving market growth.

CRISPR and Cas Gene Market- Geographical Insights:

The CRISPR and Cas gene market exhibits significant regional variations driven by differences in technological advancements, research funding, regulatory frameworks, and market adoption. North America leads the global market, attributed to substantial investments in gene-editing technologies, a robust biotechnology industry, and supportive government policies. The United States, in particular, dominates due to extensive research initiatives and collaborations between leading pharmaceutical companies and research institutions. According to the National Institutes of Health (NIH), the U.S. government allocated over $1 billion in funding for CRISPR-related research projects in recent years. Europe holds a prominent market share, driven by strong academic research infrastructure and rising adoption of CRISPR technologies in therapeutic applications. Countries like Germany, the United Kingdom, and France are at the forefront of CRISPR innovations, particularly in agricultural biotechnology and precision medicine. However, regulatory constraints around genetic modifications remain a challenge. Asia-Pacific is experiencing rapid growth, primarily fueled by expanding biotechnology industries in countries like China, Japan, and South Korea. China has emerged as a major player, with aggressive investments in gene-editing research and clinical applications, especially in agriculture and disease treatment. The region's rising focus on food security and personalized medicine further accelerates demand. Emerging markets in Latin America and the Middle East & Africa are gradually adopting CRISPR technologies, driven by agricultural advancements and healthcare modernization.

CRISPR and Cas Gene Market- Competitive Landscape:

The CRISPR and Cas gene market is highly competitive, with a mix of established players and emerging biotech firms driving innovation across various applications. Companies in the market are focusing on developing advanced CRISPR-based products, such as gene-editing kits, reagents, and CRISPR-related services, to cater to the increasing demand from the pharmaceutical, biotechnology, and agricultural sectors. These companies invest heavily in research and development to enhance the precision, efficiency, and scalability of CRISPR technology, which is vital for successful commercialization. The competitive landscape is characterized by strategic partnerships, collaborations, and acquisitions aimed at expanding product portfolios and market reach. Key players are also engaging in alliances with academic institutions and research organizations to accelerate the development of new gene-editing tools and therapies. In addition, companies are diversifying their offerings by exploring applications beyond traditional healthcare and agriculture, such as industrial biotechnology and environmental applications, to gain a competitive edge. With growing regulatory approval for CRISPR-based therapies and agriculture products, market players are positioning themselves for long-term growth in emerging markets, which presents both opportunities and challenges in navigating diverse regulatory environments. Overall, the competition is intense, driven by technological advancements, innovation, and strategic business expansion.

Recent Developments:

  • In April 2024, Cellistic successfully acquired the STAR-CRISPR Cas-12 gene-editing technology platform and its full intellectual property portfolio from Artisan Bio, enhancing its capabilities in iPSC-based allogeneic cell therapy. This acquisition strengthens Cellistic's position as a leader in gene editing, offering high precision and efficiency in cell therapy development, and allows for custom edits with greater precision than conventional CRISPR technologies.
  • In July 2024, Ncardia acquired STAR-CRISPR technology to enhance gene editing in induced pluripotent stem cells (iPSCs), offering high efficiency in gene knock-ins and knock-outs with minimal off-target effects. This acquisition strengthens their capabilities in drug discovery and regenerative medicine by providing more accurate disease models and advanced cell therapies.
  • In March 2024, Ricoh entered a licensing agreement with ERS Genomics for access to CRISPR/Cas9 genome editing technology in the USA and Japan. This collaboration, combined with Ricoh's acquisition of Elixirgen Scientific, aims to accelerate drug discovery, personalized medicine, and regenerative medicine by leveraging CRISPR to create reliable disease models, improving drug development timelines and success rates.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR AND CAS GENE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Editas Medicine
  • CRISPR Therapeutics
  • Intellia Therapeutics
  • Caribou Biosciences
  • Horizon Discovery
  • Synthego Corporation
  • Agilent Technologies
  • GenScript Biotech
  • Takara Bio
  • Promega Corporation
  • MilliporeSigma
  • Bio-Rad Laboratories
  • New England Biolabs
  • Beam Therapeutics
  • Others

GLOBAL CRISPR AND CAS GENE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • CRISPR Products
  • CRISPR Services

GLOBAL CRISPR AND CAS GENE MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Biomedical Applications
  • Agricultural Applications
  • Industrial Applications

GLOBAL CRISPR AND CAS GENE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations

GLOBAL CRISPR AND CAS GENE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR and Cas Gene Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR and Cas Gene Market Snippet by Product
    • 2.1.2. CRISPR and Cas Gene Market Snippet by Application
    • 2.1.3. CRISPR and Cas Gene Market Snippet by End-User
    • 2.1.4. CRISPR and Cas Gene Market Snippet by Country
    • 2.1.5. CRISPR and Cas Gene Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR and Cas Gene Key Market Trends

  • 3.1. CRISPR and Cas Gene Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR and Cas Gene Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR and Cas Gene Market Opportunities
  • 3.4. CRISPR and Cas Gene Market Future Trends

4. CRISPR and Cas Gene Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR and Cas Gene Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR and Cas Gene Market Landscape

  • 6.1. CRISPR and Cas Gene Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR and Cas Gene Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. CRISPR Products
    • 7.1.3. CRISPR Services

8. CRISPR and Cas Gene Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Biomedical Applications
    • 8.1.3. Agricultural Applications
    • 8.1.4. Industrial Applications

9. CRISPR and Cas Gene Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Academic and Research Institutions
    • 9.1.4. Contract Research Organizations

10. CRISPR and Cas Gene Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. CRISPR and Cas Gene Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. CRISPR and Cas Gene Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. CRISPR and Cas Gene Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. CRISPR and Cas Gene Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. CRISPR and Cas Gene Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- CRISPR and Cas Gene Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Editas Medicine
    • 11.2.3. CRISPR Therapeutics
    • 11.2.4. Intellia Therapeutics
    • 11.2.5. Caribou Biosciences
    • 11.2.6. Horizon Discovery
    • 11.2.7. Synthego Corporation
    • 11.2.8. Agilent Technologies
    • 11.2.9. GenScript Biotech
    • 11.2.10. Takara Bio
    • 11.2.11. Promega Corporation
    • 11.2.12. MilliporeSigma
    • 11.2.13. Bio-Rad Laboratories
    • 11.2.14. New England Biolabs
    • 11.2.15. Beam Therapeutics
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us